Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16374329 | 0.84 | CA12 (0.38) | CA12CA1CA2CA9MAPT | |
| SCHEMBL1526065 | 0.82 | MAPT (0.43) | CA12CA1CA2CA9MAPT | |
| SCHEMBL9683654 | 0.82 | ALDH1A1 (0.50) | CA12CA1CA2CA9MAPT | |
| SCHEMBL251699 | 0.80 | NTRK2 (0.38) | CA12CA1CA9 | |
| SCHEMBL9972956 | 0.80 | CA12 (0.31) | CA12CA1CA2CA9MAPT | |
| SCHEMBL14557535 | 0.80 | MAPT (0.41) | CA12CA1CA2CA9MAPT | |
| SCHEMBL9682862 | 0.80 | MAPT (0.41) | CA12CA1CA2CA9MAPT | |
| SCHEMBL10351406 | 0.79 | CA12 (0.43) | CA12CA1CA2CA9MAPT | |
| SCHEMBL859494 | 0.78 | APOL1 (0.33) | CA12CA1CA2CA9 | |
| SCHEMBL2493116 | 0.76 | CA12 (0.41) | CA12CA1CA2CA9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 459 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171489-B1 | SANITIZING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2026-03-25 | — | — | EP | claimed |
| US-20250361181-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | HSUSTAINABILITY GMBH (DE) | 2025-11-27 | — | — | US | claimed |
| EP-4565543-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | Heidelberg Materials AG (DE) | 2025-06-11 | — | — | EP | claimed |
| US-12042550-B2 | Leave-on hair treatment compositions | L'OREAL (FR) | 2024-07-23 | — | — | US | claimed |
| US-20240122821-A1 | LEAVE-ON HAIR TREATMENT COMPOSITIONS | L'OREAL (FR) | 2024-04-18 | — | — | US | claimed |
| WO-2024073637-A1 | LEAVE-ON HAIR TREATMENT COMPOSITIONS | L'OREAL (FR) | 2024-04-04 | — | — | WO | claimed |
| WO-2024028219-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | HEIDELBERG MATERIALS AG (DE) | 2024-02-08 | — | — | WO | claimed |
| EP-4317103-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | Heidelberg Materials AG (DE) | 2024-02-07 | — | — | EP | claimed |
| US-20230255868-A1 | SANITIZING COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-08-17 | — | — | US | claimed |
| EP-4171489-A1 | SANITIZING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-05-03 | — | — | EP | claimed |
| WO-2001016262-A2 | FABRIC CARE COMPOSITION CONTAINING POLYCARBOXYLATE POLYMER AND COMPOUND DERIVED FROM UREA | COLGATE-PALMOLIVE COMPANY (US) | 2001-03-08 | — | — | WO | claimed |
| US-6051646-A | ABRASIVE ARTICLE WITH BINDER OF CURED COMPOSITION OF A TWO OR MORE CARBOXYL, ANHYDRIDE OR AMINE-FUNCTIONAL MOLECULE AND CROSSLINKING AGENT HAVING SINGLE UREA GROUPS SEPARATED BY TWO OR MORE CARBON ATOMS FROM TWO OR MORE HYDROXYL GROUPS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2000-04-18 | — | — | US | claimed |
| EP-0969138-A1 | Method for imparting permanent press to textiles | National Starch and Chemical Investment Holding Corporation (US) | 2000-01-05 | — | — | EP | claimed |
| US-5965466-A | HEATING THE TEXTILE TO REACT WITH THE CROSSLINKING AGENT SELECTED FROM THE GROUP CONSISTING OF (HYDROXYALKYL)UREA, HYDROXYALKYLAMIDE AND COMBINATIONS THEREOF; RESISTANCE TO LAUNDERING ABRASION, WRINKLES AND RETAIN SOFTNESS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1999-10-12 | — | — | US | claimed |
| EP-0908552-A2 | Crosslinkable fabric care compositions | National Starch and Chemical Investment Holding Corporation (US) | 1999-04-14 | — | — | EP | claimed |
| US-5879749-A | AQUEOUS SOLUTION OF A POLYMER HAVING AT LEAST TWO CARBOXYL GROUPS, SUCH AS POLYACRYLIC ACID, A POLY(HYDROXY) CROSSLINKING AGENT; IMPARTS STAIN RESISTANCE AND WRINKLE RESISTANCE TO FABRICS, LEAVES NO RESIDUE | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1999-03-09 | — | — | US | claimed |
| US-5858549-A | FORMALDEHYDE FREE | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1999-01-12 | — | — | US | claimed |
| EP-0888402-A1 | (HYDROXYALKYL)UREA CROSSLINKING AGENTS | National Starch and Chemical Investment Holding Corporation (US) | 1999-01-07 | — | — | EP | claimed |
| WO-1998030627-A1 | (HYDROXYALKYL)UREA CROSSLINKING AGENTS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1998-07-16 | — | — | WO | claimed |
| US-5324446-A | Adding urea compound as stabilizer | MILES INC. (US) | 1994-06-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12042550-B2 | Leave-on hair treatment compositions | ALG3, DEGS1, DSG1 | CA12 1054/4885CA1 1819/4885CA2 3802/4885 |
| US-20240122821-A1 | LEAVE-ON HAIR TREATMENT COMPOSITIONS | ALG3, DEGS1, DSG1 | CA12 1054/4885CA1 1819/4885CA2 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.